ACGL vs CB

• ACGLSell somesales growth, past year−3.9%

  Arch Capital's sales fell 3.9% over the past year, and the stock rose 14% over the past month, in step with other insurers (up 15%).

• CBBuy more17%

  Chubb's report on Oct 20 beat profit forecasts by 17%, and its sales grew 5.3% over the past year.

Percent return

• ACGL+20.42%
• CB+27.80%

1M6MYTD1Y5YMax

Nov 11, 2025 to Nov 11, 2026

Where they differ

Even, 3 each of 6

ACGLCB

• Company size: ACGL $36.5B, CB $140B.
  $36.5BCompany sizebigger$140B
• Sales growth, 1 yr: ACGL −3.9%, CB +5.3%. CB is ahead.
  −3.9%Sales growth, 1 yr+5.3%
• Price for $1 of next year's profit: ACGL $11, CB $13. ACGL is ahead.
  $11cheaperPrice for $1 of next year's profit$13
• Profit per $1 of sales: ACGL 27¢, CB 22¢. ACGL is ahead.
  27¢Profit per $1 of sales22¢
• Cash minus debt: ACGL −$3.13B, CB −$23.1B. ACGL is ahead.
  −$3.13BCash minus debt−$23.1B
• Price change, 1 yr: ACGL +20%, CB +28%. CB is ahead. S&P 500 +12%.
  +20%Price change, 1 yr+28%
• How much the price swings: ACGL 22%, CB 21%. CB is ahead.
  22%How much the price swingssteadier21%

Measure	ACGLArch Capital	CBChubb
Price and returns
Price	$109.18	$370.29
Today	+0.04%	Best in this row: +0.32%
1 month	Best in this row: +14.23%	+8.54%
3 months	Best in this row: +11.11%	+7.01%
This year	+13.81%	Best in this row: +19.73%
1 year	+20.42%	Best in this row: +27.80%
5 years	Best in this row: +176.84%	+104.87%
From 52-week high	−1.4%	−1.0%
How much it swings (90 days)	22%	Best in this row: 21%
Valuation
Market value	$36.5B	$140B
Price vs last year's earnings	Best in this row: 8.0×	12.8×
Price vs next year's expected earnings	Best in this row: 10.9×	12.6×
Price vs earnings, adjusted for growth	3.59×	Best in this row: 1.33×
Price to sales	Best in this row: 1.9×	2.3×
Price vs cash it brings in	6.2×	–
Company value vs operating profit	Best in this row: 7.3×	11.6×
Growth
Revenue growth, 1 year	−3.9%	Best in this row: +5.3%
Revenue growth a year, last 3 years	Best in this row: +27.5%	+11.8%
Earnings per share growth, last year	+33.0%	Best in this row: +35.9%
Earnings per share growth expected next year	−2.1%	Best in this row: +1.3%
Profitability
Kept as operating profit	Best in this row: 27.1%	22.2%
Kept as final profit	Best in this row: 23.1%	18.1%
Kept as spare cash	Best in this row: 30.0%	28.8%
Profit on shareholders' money	Best in this row: 18.7%	14.3%
Profit on all money put in	Best in this row: 15.9%	10.6%
Balance sheet
Net cash (cash minus debt)	Best in this row: −$3.13B	−$23.1B
Debt for each $1 of shareholders' money	Best in this row: 0.19×	0.33×
Short-term assets per $1 of bills due	Best in this row: 0.58×	0.40×
Dividend yield	–	1.12%
Share of profit paid as dividends	–	14%
Our readPro
Our call	Sell some	Buy more
Why	Arch Capital's sales fell 3.9% over the past year, and the stock rose 14% over the past month, in step with other insurers (up 15%).	Chubb's report on Oct 20 beat profit forecasts by 17%, and its sales grew 5.3% over the past year.
Where the price sits	–	in the full report
Our overall score (out of 100)	Best in this row: 68	68
Our value score	Best in this row: 72	70
Our growth score	58	Best in this row: 66
Our quality score	Best in this row: 85	79
Our price trend score	Best in this row: 66	59
Earnings and analysts
Analyst consensus	Hold	Hold
To average analyst target	Best in this row: +1.7%	+0.9%
Average analyst target	$111.00	$373.67
Analysts rating it a buy	Best in this row: 45%	36%
Buy ratings added, 3 months	−1	Best in this row: 0
Analysts covering	16	15

CB: our only Buy more, with faster sales growth

Our pick of these: Chubb

Buy more69/100

Sales growth +5.3% vs −3.9%

ACGL −3.9%, CB +5.3%.

ACGL−3.9%

CB+5.3%

Forward P/E per point of sales growth 2.39 vs no growth

ACGL no growth, CB 2.39.

ACGLno growth

CB2.39

1-year return +27.8% vs +20.4%, S&P 500 +12.4%

ACGL +20.4%, CB +27.8%.

ACGL+20.4%

CB+27.8%

Where it loses: ACGL has wider profit margins, 27.1% vs 22.2%

• 2ndACGLSell some31/100Would need our call to move up from Sell some

Prices as of yesterday, 3:59 PM ET. A view, not advice.